Population Pharmacokinetic Analysis of Indacaterol/Glycopyrronium/Mometasone Furoate After Administration of Combination Therapies Using the Breezhaler(®) Device in Patients with Asthma

BACKGROUND AND OBJECTIVE: Clinical evidence suggests no clinically relevant pharmacokinetic interactions between indacaterol (IND), glycopyrronium (GLY) and mometasone furoate (MF). A population pharmacokinetic (popPK) analysis was conducted to identify structural models describing systemic pharmaco...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartels, Christian, Jain, Monish, Yu, Jing, Tillmann, Hanns-Christian, Vaidya, Soniya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298373/
https://www.ncbi.nlm.nih.gov/pubmed/34024035
http://dx.doi.org/10.1007/s13318-021-00689-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298373/
https://www.ncbi.nlm.nih.gov/pubmed/34024035
http://dx.doi.org/10.1007/s13318-021-00689-x

Ejemplares similares